781
Participants
Start Date
February 28, 2018
Primary Completion Date
November 30, 2021
Study Completion Date
June 3, 2022
Secukinumab
Secukinumab 300 mg s.c., which consisted of two injections with 150 mg prefilled syringes at weeks 0, 1, 2, 3, 4, 8, 12, 16, 20 and 24 (last injection was performed at week 24)
Life-style intervention
A structured program to guide weight loss and increased physical activity
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Potsdam
Novartis Investigative Site, Falkensee
Novartis Investigative Site, Greifswald
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Kiel
Novartis Investigative Site, Oldenburg
Novartis Investigative Site, Hanover
Novartis Investigative Site, Löhne
Novartis Investigative Site, Detmold
Novartis Investigative Site, Bielefeld
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Braunschweig
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Mönchengladbach
Novartis Investigative Site, Wuppertal
Novartis Investigative Site, Wuppertal
Novartis Investigative Site, Remscheid
Novartis Investigative Site, Bochum
Novartis Investigative Site, Bochum
Novartis Investigative Site, Oberhausen
Novartis Investigative Site, Münster
Novartis Investigative Site, Osnabrück
Novartis Investigative Site, Vechta
Novartis Investigative Site, Ibbenbueren
Novartis Investigative Site, Bramsche
Novartis Investigative Site, Lingen
Novartis Investigative Site, Cologne
Novartis Investigative Site, Bonn
Novartis Investigative Site, Mainz
Novartis Investigative Site, Simmern
Novartis Investigative Site, Selters
Novartis Investigative Site, Andernach
Novartis Investigative Site, Hagen
Novartis Investigative Site, Lüdenscheid
Novartis Investigative Site, Soest
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Hanau
Novartis Investigative Site, Seligenstadt
Novartis Investigative Site, Darmstadt
Novartis Investigative Site, Bad Soden
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, München
Novartis Investigative Site, München
Novartis Investigative Site, München
Novartis Investigative Site, Augsburg
Novartis Investigative Site, Memmingen
Novartis Investigative Site, Friedrichshafen
Novartis Investigative Site, Ulm
Novartis Investigative Site, Langenau
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Pommelsbrunn
Novartis Investigative Site, Dresden
Novartis Investigative Site, Dresden
Novartis Investigative Site, Gera
Novartis Investigative Site, Halle
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Plauen
Novartis Investigative Site, Quedlinburg
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY